… the efficacy and safety of rivaroxaban in patients with non-valvular atrial fibrillation and renal
… A total of 297 patients with non-valvular atrial fibrillation and renal insufficiency who were …

… the effectiveness and safety of … to warfarin in terms of effectiveness and safety. By comparing
different direct oral anticoagulants, apixaban outperformed dabigatran and rivaroxaban. …

… 维生素K 拮抗剂华法林是经典的抗凝药物,通 过竞争性对抗维生素K,减少凝血因子Ⅱ,Ⅶ,Ⅸ, Ⅹ的
合成和活性发挥作用,在瓣膜性及非瓣膜性房 颤(non-valvular atrial fibrillation,NVAF)中都可…

… The aim of this study was to evaluate the long-term efficacy of LAAO in DM patients with
AF. … of last follow-up between groups in the present study. The safety, efficacy, and short-term …

… Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with
nonvalvular atrial fibrillation: A … Assessment of female sex as a risk factor in atrial fibrillation in …

… 05),and the risk of Rivaroxaban bleeding was … Rivaroxaban and Dabigatran are similar in
efficacy in elderly patients with non-valvular atrial fibrillation,but the safety of Rivaroxaban are …

… Comparative study for effectiveness and safety in treating non-valvular atrial fibrillation
between rivaroxaban and warfarin[J].Practical Journal of Cardiac Cerebral Pneumal and …

… with atrial fibrillation(AF) … , efficacy, and safety require special consideration in patients with
CKD.This review is intended to explore the pharmacokinetic changes and safety and efficacy …

… Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation:
the rivaroxaban … of stroke and embolism trial in atrial fibrillation (ROCKET AF Trial)[J]. Am …

… Objective: To investigate the efficacy and safety of rivaroxaban versus warfarin in …
ablation of atrial fibrillation. Methods: A total of 80 patients with atrial fibrillation undergoing …